LIXTE BIOTECHNOLOGY HOLDINGS, INC. (LIXT)
↓ Download CSV- Sector Manufacturing
- Incorporated DE
- Fiscal year ends Dec 31
Key ratios (FY2025)
-62.9%
Return on equity
| Metric (FY) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Income | -$5.11M | -$3.57M | -$5.09M | -$6.31M | -$6.72M | -$3.27M | -$2.49M | -$2.14M | -$1.81M | -$2.13M |
| Net Income | -$6.08M | -$3.59M | -$5.09M | -$6.31M | -$6.73M | -$3.26M | -$2.44M | -$2.13M | -$1.81M | -$2.13M |
| EPS (Diluted) | $-1.26 | $-1.59 | $-2.66 | $-3.99 | — | — | — | — | — | — |
| Total Assets | $12.73M | $1.15M | $4.31M | $5.56M | $5.09M | $5.23M | $2.67M | $4.34M | $1.37M | $433.4K |
| Total Liabilities | $1.77M | $318.3K | — | — | — | — | — | — | — | $218.7K |
| Shareholders' Equity | $9.66M | $827.2K | $3.99M | $5.17M | $4.79M | $5.01M | $2.43M | $4.13M | $995.0K | $214.8K |
| Cash & Equivalents | — | — | $4.20M | $5.35M | $4.82M | $5.07M | $2.60M | $4.27M | $1.31M | $199.9K |
| Operating Cash Flow | -$3.07M | -$3.16M | -$4.29M | -$4.61M | -$4.14M | -$2.13M | $1.67M | -$1.51M | -$1.41M | -$1.68M |
| Shares Outstanding | 8.79M | 2.25M | 2.25M | 1.66M | 13.75M | 12.40M | 11.17M | 67.05M | 58.03M | 47.88M |